Sakai, Japan

Eiji Kasamatsu


Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Sakai-gun, JP (2009)
  • Sakai, JP (2010 - 2012)

Company Filing History:


Years Active: 2009-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Eiji Kasamatsu: Innovator in Pharmaceutical Crystallization

Introduction

Eiji Kasamatsu is a notable inventor based in Sakai, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative crystal formulations. With a total of 3 patents to his name, his work focuses on enhancing the safety and efficacy of medicinal compounds.

Latest Patents

Kasamatsu's latest patents include the development of crystals comprising (2R)-2-propyloctanoic acid and an amine. These crystals are designed to be used as bulk drugs for safely orally administrable solid preparations while maintaining their pharmacological effects. Among these innovations, the crystal with dibenzylamine is particularly noteworthy, as it serves as a bulk drug for pharmaceuticals and can be utilized as an intermediate to produce (2R)-2-propyloctanoic acid with an optical purity exceeding 99.5% e.e., a feat not previously achieved.

Career Highlights

Eiji Kasamatsu is associated with Ono Pharmaceutical Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in developing safer and more effective medicinal raw drugs, particularly for peroral solid preparations.

Collaborations

Kasamatsu has collaborated with esteemed colleagues such as Tomoyuki Hasegawa and Yasufumi Kawanaka. Their combined expertise has contributed to the advancement of pharmaceutical innovations.

Conclusion

Eiji Kasamatsu's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work not only enhances drug safety but also paves the way for future advancements in medicinal formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…